This is a preview of subscription content, log in via an institution to check access.
Reference
Decision Resources. The Approval Of The First Biosimilar Monoclonal Antibody In Europe Has Major Implications For 2014 And Beyond. Media Release : 5 Dec 2013. Available from: URL: http://www.decisionresources.com
Rights and permissions
About this article
Cite this article
Implications of approval of first biosimilar MAb in Europe. PharmacoEcon Outcomes News 693, 11 (2013). https://doi.org/10.1007/s40274-013-0951-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0951-z